In silico analysis of TCGA data showed that a high mRNA expression of ADORA2B was associated with a poor disease-free survival of pancreatic adenocarcinoma patients (Figure 8D). The gene discussed is ADORA2B; the disease is pancreatic adenocarcinoma.